MARKET

VIVE

VIVE

Viveve Medical
NASDAQ

Real-time Quotes | Nasdaq Last Sale

0.6086
-0.0211
-3.35%
Closed 16:00 04/02 EDT
OPEN
0.6460
PREV CLOSE
0.6297
HIGH
0.6460
LOW
0.5706
VOLUME
244.84K
TURNOVER
--
52 WEEK HIGH
94.00
52 WEEK LOW
0.5401
MARKET CAP
6.10M
P/E (TTM)
-0.0101
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 1 analysts

Strong Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average VIVE stock price target is 4.000 with a high estimate of 4.000 and a low estimate of 4.000.

EPS

VIVE News

More
  • Edited Transcript of VIVE earnings conference call or presentation 19-Mar-20 9:00pm GMT
  • Thomson Reuters StreetEvents · 03/26 21:48
  • Viveve Announces Clearance of Next Generation 2.0 System in Taiwan
  • ACCESSWIRE · 03/26 13:28
  • Viveve Medical, Inc. (VIVE) CEO Scott Durbin on Q4 2019 - Earnings Call Transcript
  • Seeking Alpha - Transcript · 03/20 02:57
  • Viveve Reports Full Year 2019 Financial Results
  • ACCESSWIRE · 03/19 21:01

Industry

Advanced Medical Equipment & Technology
+4.07%
Healthcare Equipment & Supplies
+3.33%

Hot Stocks

Symbol
Price
%Change

About VIVE

Viveve Medical, Inc. designs, develops, manufactures and markets a medical device, Geneveve, for the non-invasive treatment of vaginal laxity, for improved sexual function, and for vaginal rejuvenation. The Company's, Geneveve, is a non-invasive solution for vaginal laxity, which includes three components: the Viveve System (a radio frequency (RF), generator housed in a table-top console), a reusable handpiece and a single-use treatment tip, as well as several other consumable accessories. Physicians attach the single-use treatment tip to the handpiece, which is connected to the console. The generator authenticates the treatment tip and programs the system for the desired treatment without further physician intervention. The treatment is performed in a physician's office, in less than 30 minutes, and does not require the use of anesthesia. Geneveve is indicated for use in general surgical procedures for electrocoagulation and hemostasis in the United States.
More

Webull offers kinds of Viveve Medical Inc stock information, including NASDAQ:VIVE real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, VIVE stock news, and many more online research tools to help you make informed decisions.